Watchlist Manager

Watchlist

Price: 3 996.5 INR 0.23% Market Closed

Market Cap: ₹1.4T

T	Torrent Pharmaceuticals Ltd NSE:TORNTPHARM	IN
	Antengene Corporation Ltd HKEX:6996	CN

Income Statement

Currency: INR

	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	100	0	0	0	236	0	0	0	229	0	0	0	393	0	0	0	291	0	0	0	300	0	0	0	302	0	0	0	258	0	0	0	342	0	0	0	1 559	0	0	0	1 833	0	0	0	2 029	0	0	0	3 048	0	0	0	5 011	0	0	0	4 484	0	0	0	3 562	0	0	0	2 529	0	0	0	3 322	0	0	0	3 526	0	0	0	0	0	0	0
Revenue	9 536 N/A	10 425 +9%	11 164 +7%	11 871 +6%	12 879 +8%	12 996 +1%	13 181 +1%	13 300 +1%	13 548 +2%	14 197 +5%	14 879 +5%	15 816 +6%	16 307 +3%	17 212 +6%	17 983 +4%	18 458 +3%	19 040 +3%	19 760 +4%	20 779 +5%	21 753 +5%	21 978 +1%	23 276 +6%	24 310 +4%	25 480 +5%	26 959 +6%	28 207 +5%	29 130 +3%	30 160 +4%	32 111 +6%	34 162 +6%	36 110 +6%	38 285 +6%	41 847 +9%	43 267 +3%	45 717 +6%	47 247 +3%	46 535 -2%	54 865 +18%	59 625 +9%	63 365 +6%	66 869 +6%	62 889 -6%	60 249 -4%	59 259 -2%	58 569 -1%	56 679 -3%	56 559 0%	56 759 +0%	59 498 +5%	64 598 +9%	69 368 +7%	75 248 +8%	76 728 +2%	78 228 +2%	79 338 +1%	78 488 -1%	79 393 +1%	79 733 +0%	79 853 +0%	80 143 +0%	80 048 0%	80 828 +1%	82 028 +1%	83 158 +1%	85 080 +2%	87 210 +3%	88 750 +2%	92 580 +4%	96 202 +4%	98 642 +3%	102 332 +4%	104 742 +2%	107 278 +2%	109 958 +2%	112 248 +2%	113 018 +1%	115 161 +2%	118 351 +3%	122 481 +3%	127 421 +4%
Gross Profit
Cost of Revenue	(3 422)	(5 689)	(6 413)	(7 140)	(4 485)	(6 476)	(5 691)	(4 705)	(4 741)	(4 985)	(5 000)	(5 196)	(5 953)	(5 459)	(5 603)	(5 631)	(5 859)	(5 846)	(6 311)	(6 666)	(7 299)	(7 284)	(7 673)	(8 125)	(8 989)	(8 872)	(8 820)	(9 064)	(9 679)	(10 098)	(10 939)	(11 652)	(13 005)	(12 405)	(13 205)	(13 745)	(14 746)	(15 318)	(15 268)	(15 268)	(17 457)	(15 963)	(16 213)	(17 133)	(19 298)	(17 567)	(17 737)	(17 017)	(17 768)	(18 305)	(19 605)	(21 485)	(23 217)	(22 207)	(22 107)	(21 727)	(22 525)	(21 429)	(21 589)	(21 789)	(22 353)	(21 994)	(22 404)	(23 164)	(25 375)	(25 140)	(25 600)	(26 520)	(28 277)	(27 252)	(27 442)	(27 112)	(27 877)	(27 302)	(27 482)	(27 242)	(28 845)	(28 559)	(29 779)	(31 039)
Gross Profit	6 114 N/A	4 735 -23%	4 750 +0%	4 730 0%	8 394 +77%	6 519 -22%	7 489 +15%	8 595 +15%	8 807 +2%	9 213 +5%	9 880 +7%	10 620 +7%	10 354 -3%	11 752 +14%	12 379 +5%	12 826 +4%	13 181 +3%	13 914 +6%	14 468 +4%	15 088 +4%	14 679 -3%	15 994 +9%	16 639 +4%	17 356 +4%	17 970 +4%	19 335 +8%	20 310 +5%	21 096 +4%	22 432 +6%	24 064 +7%	25 171 +5%	26 633 +6%	28 842 +8%	30 862 +7%	32 512 +5%	33 502 +3%	31 789 -5%	39 546 +24%	44 356 +12%	48 096 +8%	49 412 +3%	46 927 -5%	44 037 -6%	42 127 -4%	39 271 -7%	39 113 0%	38 823 -1%	39 743 +2%	41 730 +5%	46 294 +11%	49 764 +7%	53 764 +8%	53 511 0%	56 021 +5%	57 231 +2%	56 761 -1%	56 868 +0%	58 304 +3%	58 264 0%	58 354 +0%	57 695 -1%	58 834 +2%	59 624 +1%	59 994 +1%	59 706 0%	62 070 +4%	63 150 +2%	66 060 +5%	67 925 +3%	71 390 +5%	74 890 +5%	77 630 +4%	79 401 +2%	82 656 +4%	84 766 +3%	85 776 +1%	86 316 +1%	89 792 +4%	92 702 +3%	96 382 +4%
Operating Income
Operating Expenses	(5 424)	(4 146)	(4 135)	(3 970)	(7 274)	(5 571)	(6 501)	(7 379)	(7 167)	(7 255)	(7 621)	(8 171)	(7 745)	(9 328)	(9 448)	(9 552)	(9 746)	(10 238)	(10 828)	(11 431)	(11 417)	(12 205)	(12 635)	(13 321)	(13 556)	(15 087)	(15 947)	(16 345)	(16 287)	(17 457)	(18 344)	(19 274)	(19 314)	(20 847)	(21 897)	(22 967)	(23 494)	(25 942)	(26 342)	(26 352)	(24 458)	(26 832)	(27 912)	(29 162)	(28 433)	(29 929)	(29 799)	(30 499)	(32 324)	(35 787)	(38 497)	(41 097)	(39 824)	(41 827)	(42 467)	(42 277)	(41 679)	(41 954)	(40 994)	(40 454)	(39 411)	(40 435)	(41 005)	(42 065)	(42 012)	(43 929)	(44 769)	(46 079)	(46 524)	(49 605)	(52 025)	(54 395)	(53 678)	(55 993)	(56 933)	(57 353)	(57 055)	(59 291)	(60 821)	(62 831)
Selling, General & Administrative	(1 798)	(3 358)	(3 246)	(3 001)	(2 488)	(3 481)	(3 408)	(3 368)	(2 325)	(2 326)	(2 388)	(2 423)	(2 569)	(2 652)	(2 759)	(2 923)	(7 328)	(3 344)	(3 569)	(3 782)	(7 657)	(4 232)	(4 539)	(4 898)	(9 210)	(5 579)	(5 836)	(6 036)	(10 828)	(6 422)	(6 687)	(6 939)	(17 439)	(7 531)	(7 951)	(8 151)	(20 203)	(8 648)	(8 478)	(8 498)	(18 804)	(8 874)	(9 394)	(9 714)	(21 888)	(10 044)	(10 284)	(10 674)	(24 211)	(12 183)	(12 783)	(13 743)	(28 978)	(14 388)	(14 538)	(14 398)	(29 089)	(14 210)	(14 260)	(14 350)	(28 230)	(14 516)	(14 776)	(15 026)	(30 606)	(15 615)	(15 665)	(16 015)	(34 472)	(17 567)	(18 657)	(19 387)	(39 657)	(20 354)	(20 754)	(21 284)	(42 820)	(22 584)	(23 424)	(24 444)
Research & Development	(564)	(515)	(591)	(648)	(770)	(869)	(926)	(965)	(972)	(1 022)	(1 037)	(1 060)	(1 119)	(1 226)	(1 204)	(1 234)	(1 202)	(1 146)	(1 215)	(1 283)	0	0	0	0	0	0	0	0	0	0	0	0	(173)	0	0	0	(149)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(925)	0	0	0	(252)	0	0	0	(387)	0	0	0	(313)	0	0	0	(247)	0	0	0	(304)	0	0	0
Depreciation & Amortization	(255)	(280)	(300)	(323)	(329)	(342)	(355)	(357)	(388)	(387)	(396)	(412)	(423)	(448)	(475)	(492)	(661)	(691)	(719)	(758)	(626)	(685)	(731)	(767)	(817)	(816)	(818)	(825)	(827)	(836)	(853)	(859)	(870)	(870)	(1 210)	(1 540)	(1 907)	(2 267)	(2 297)	(2 347)	(2 376)	(2 486)	(2 586)	(2 726)	(2 934)	(3 189)	(3 339)	(3 549)	(4 086)	(4 786)	(5 466)	(6 086)	(6 144)	(6 277)	(6 387)	(6 457)	(6 515)	(6 554)	(6 574)	(6 614)	(6 573)	(6 618)	(6 648)	(6 648)	(6 619)	(6 522)	(6 472)	(6 732)	(7 020)	(7 426)	(7 806)	(8 006)	(7 953)	(8 143)	(8 113)	(7 973)	(7 949)	(7 989)	(8 049)	(8 119)
Other Operating Expenses	(2 807)	7	0	0	(3 687)	(880)	(1 812)	(2 688)	(3 482)	(3 519)	(3 800)	(4 277)	(3 634)	(5 004)	(5 012)	(4 904)	(555)	(5 059)	(5 326)	(5 609)	(3 135)	(7 288)	(7 365)	(7 656)	(3 529)	(8 693)	(9 293)	(9 484)	(4 632)	(10 199)	(10 805)	(11 477)	(832)	(12 446)	(12 736)	(13 276)	(1 235)	(15 026)	(15 566)	(15 506)	(3 278)	(15 473)	(15 933)	(16 723)	(3 610)	(16 696)	(16 176)	(16 276)	(4 026)	(18 819)	(20 249)	(21 269)	(4 702)	(21 163)	(21 543)	(21 423)	(5 150)	(21 190)	(20 160)	(19 490)	(4 357)	(19 301)	(19 581)	(20 391)	(4 400)	(21 793)	(22 633)	(23 333)	(4 719)	(24 612)	(25 562)	(27 002)	(5 821)	(27 496)	(28 066)	(28 096)	(5 982)	(28 718)	(29 348)	(30 268)
Operating Income	690 N/A	590 -14%	615 +4%	760 +24%	1 120 +47%	949 -15%	989 +4%	1 216 +23%	1 640 +35%	1 957 +19%	2 257 +15%	2 448 +8%	2 609 +7%	2 423 -7%	2 931 +21%	3 274 +12%	3 435 +5%	3 676 +7%	3 641 -1%	3 658 +0%	3 262 -11%	3 789 +16%	4 003 +6%	4 035 +1%	4 414 +9%	4 249 -4%	4 364 +3%	4 751 +9%	6 145 +29%	6 607 +8%	6 827 +3%	7 359 +8%	9 528 +29%	10 015 +5%	10 615 +6%	10 535 -1%	8 295 -21%	13 604 +64%	18 014 +32%	21 744 +21%	24 955 +15%	20 095 -19%	16 125 -20%	12 965 -20%	10 839 -16%	9 184 -15%	9 024 -2%	9 244 +2%	9 407 +2%	10 507 +12%	11 267 +7%	12 667 +12%	13 687 +8%	14 194 +4%	14 764 +4%	14 484 -2%	15 189 +5%	16 350 +8%	17 270 +6%	17 900 +4%	18 284 +2%	18 399 +1%	18 619 +1%	17 929 -4%	17 693 -1%	18 141 +3%	18 381 +1%	19 981 +9%	21 400 +7%	21 785 +2%	22 865 +5%	23 235 +2%	25 724 +11%	26 664 +4%	27 834 +4%	28 424 +2%	29 261 +3%	30 501 +4%	31 881 +5%	33 551 +5%
Pre-Tax Income
Interest Income Expense	(52)	(84)	(98)	(144)	(162)	(175)	(201)	(184)	(196)	(209)	(216)	(201)	(602)	(162)	(165)	(159)	44	(160)	(135)	(140)	169	(199)	(265)	(333)	(162)	(392)	(372)	(336)	90	(324)	(394)	(487)	(1 011)	(746)	(1 136)	(1 476)	1 158	(2 062)	(2 002)	(1 932)	(154)	(1 780)	(1 810)	(1 860)	193	(2 126)	(2 126)	(2 446)	(82)	(3 745)	(4 495)	(5 025)	(4 465)	(5 038)	(4 938)	(4 718)	(3 285)	(4 307)	(4 067)	(3 867)	(3 035)	(3 243)	(3 033)	(2 743)	(661)	(2 421)	(2 401)	(2 801)	(3 160)	(3 814)	(4 034)	(3 814)	(3 271)	(3 256)	(2 986)	(2 756)	(2 311)	(2 333)	(2 173)	(2 053)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	(88)	(88)	(88)	(88)	0	0	0	0	0	0	0	0	0	(654)	(654)	(654)	(654)	(375)	(375)	(375)	(375)	0	0	0	0	0	0	0	(1 940)	(1 936)	(1 936)	(1 936)	4	(135)	0	0	0	0	0	0	0	(3 603)	(3 570)	(3 570)	(3 570)	(29)	0	0	0	(5)	0	0	0	(4 849)	(4 847)	(4 847)	(4 847)	(46)	0	0	880	(130)	0	0	0	(242)	(242)	(372)	(472)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	(32)	0	0	0	(9)	0	0	0	(10)	0	0	0	(16)	0	0	0	(50)	0	0	0	(41)	0	0	0	11	0	0	0	34	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	216	0	0	880	884	884	0	0	13	0	0	0
Total Other Income	139	144	152	189	132	394	440	411	47	(28)	(136)	(201)	35	48	35	35	1	92	110	104	2	174	233	337	3	470	509	476	5	374	351	362	(36)	791	1 411	1 961	(66)	3 116	3 106	3 006	536	1 766	1 486	1 436	(16)	3 023	3 373	3 613	(15)	2 208	1 528	818	(2)	501	741	1 241	(10)	1 053	773	323	19	927	1 377	1 777	76	1 866	1 516	936	61	491	591	361	314	479	943	723	7	(377)	(487)	(947)
Pre-Tax Income	777 N/A	651 -16%	669 +3%	804 +20%	1 090 +36%	1 167 +7%	1 228 +5%	1 443 +18%	1 491 +3%	1 719 +15%	1 903 +11%	1 956 +3%	1 922 -2%	2 221 +16%	2 714 +22%	3 151 +16%	3 472 +10%	3 608 +4%	3 616 +0%	3 622 +0%	3 423 -5%	3 763 +10%	3 970 +6%	4 038 +2%	3 586 -11%	3 673 +2%	3 848 +5%	4 237 +10%	5 816 +37%	6 282 +8%	6 408 +2%	6 859 +7%	8 440 +23%	10 060 +19%	10 890 +8%	11 020 +1%	9 398 -15%	14 658 +56%	19 118 +30%	20 878 +9%	23 434 +12%	18 144 -23%	13 864 -24%	12 544 -10%	10 881 -13%	10 081 -7%	10 271 +2%	10 411 +1%	9 310 -11%	8 970 -4%	8 300 -7%	8 460 +2%	5 617 -34%	6 087 +8%	6 997 +15%	7 437 +6%	11 866 +60%	13 096 +10%	13 976 +7%	14 356 +3%	15 263 +6%	16 083 +5%	16 963 +5%	16 963 N/A	12 259 -28%	12 739 +4%	12 649 -1%	13 269 +5%	18 472 +39%	18 462 0%	19 422 +5%	21 542 +11%	23 521 +9%	24 771 +5%	25 791 +4%	26 391 +2%	26 728 +1%	27 548 +3%	28 848 +5%	30 078 +4%
Net Income
Tax Provision	(188)	(188)	(149)	(90)	(155)	(127)	(154)	(253)	(144)	(148)	(112)	(30)	(78)	(720)	(955)	(1 069)	(1 160)	(704)	(690)	(757)	(722)	(777)	(739)	(737)	(723)	(807)	(904)	(1 012)	(1 467)	(1 473)	(1 554)	(1 545)	(1 801)	(2 351)	(2 331)	(2 371)	(1 888)	(3 208)	(4 558)	(5 088)	(6 102)	(4 392)	(3 132)	(2 422)	(1 545)	(1 785)	(2 005)	(3 855)	(2 529)	(2 439)	(2 019)	(299)	(1 254)	(1 194)	(1 454)	(1 844)	(2 147)	(2 327)	(2 547)	(2 467)	(2 744)	(3 474)	(4 294)	(4 774)	(4 487)	(4 727)	(4 677)	(4 957)	(6 019)	(5 769)	(5 989)	(6 509)	(6 957)	(7 417)	(7 767)	(7 767)	(7 616)	(7 526)	(7 446)	(7 356)
Income from Continuing Operations	589	463	521	716	935	1 042	1 075	1 191	1 347	1 572	1 793	1 927	1 844	1 502	1 759	2 082	2 312	2 903	2 925	2 864	2 702	2 985	3 231	3 301	2 863	2 867	2 944	3 226	4 349	4 809	4 854	5 313	6 639	7 709	8 559	8 649	7 510	11 450	14 560	15 790	17 333	13 753	10 733	10 123	9 336	8 296	8 266	6 556	6 781	6 531	6 281	8 161	4 363	4 893	5 543	5 593	9 719	10 769	11 429	11 889	12 519	12 609	12 669	12 189	7 772	8 012	7 972	8 312	12 452	12 692	13 432	15 032	16 564	17 354	18 024	18 624	19 113	20 023	21 403	22 723
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	(9)	(16)	(23)	(22)	(26)	(16)	(22)	(9)	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	509 N/A	382 -25%	440 +15%	635 +44%	935 +47%	1 042 +11%	1 075 +3%	1 191 +11%	1 347 +13%	1 572 +17%	1 793 +14%	1 927 +7%	1 844 -4%	1 502 -19%	1 759 +17%	2 082 +18%	2 312 +11%	2 903 +26%	2 925 +1%	2 864 -2%	2 702 -6%	2 984 +10%	3 222 +8%	3 285 +2%	2 840 -14%	2 845 +0%	2 918 +3%	3 209 +10%	4 328 +35%	4 799 +11%	4 856 +1%	5 313 +9%	6 639 +25%	7 709 +16%	8 559 +11%	8 649 +1%	7 509 -13%	11 449 +52%	14 559 +27%	15 789 +8%	17 332 +10%	13 752 -21%	10 732 -22%	10 122 -6%	9 336 -8%	8 296 -11%	8 266 0%	6 556 -21%	6 781 +3%	6 531 -4%	6 281 -4%	8 161 +30%	4 363 -47%	4 893 +12%	5 543 +13%	5 593 +1%	10 247 +83%	11 297 +10%	11 957 +6%	12 417 +4%	12 519 +1%	12 609 +1%	12 669 +0%	12 189 -4%	7 772 -36%	8 012 +3%	7 972 0%	8 312 +4%	12 452 +50%	12 692 +2%	13 432 +6%	15 032 +12%	16 564 +10%	17 354 +5%	18 024 +4%	18 624 +3%	19 113 +3%	20 023 +5%	21 403 +7%	22 723 +6%
EPS (Diluted)	1.5 N/A	1.13 -25%	1.29 +14%	1.87 +45%	2.76 +48%	3.08 +12%	3.17 +3%	3.51 +11%	3.98 +13%	4.64 +17%	5.3 +14%	5.7 +8%	5.45 -4%	4.45 -18%	5.21 +17%	6.16 +18%	6.83 +11%	8.58 +26%	8.64 +1%	8.46 -2%	7.98 -6%	8.82 +11%	9.52 +8%	9.71 +2%	8.39 -14%	8.31 -1%	8.63 +4%	9.49 +10%	12.79 +35%	14.18 +11%	14.35 +1%	15.7 +9%	19.64 +25%	22.8 +16%	25.32 +11%	25.58 +1%	22.21 -13%	33.87 +52%	43.07 +27%	46.71 +8%	51.27 +10%	40.68 -21%	31.74 -22%	29.94 -6%	27.62 -8%	24.54 -11%	24.45 0%	19.39 -21%	20.06 +3%	19.37 -3%	18.52 -4%	24.13 +30%	12.89 -47%	14.46 +12%	16.44 +14%	16.56 +1%	30.31 +83%	33.42 +10%	35.37 +6%	36.62 +4%	37.03 +1%	37.3 +1%	37.37 +0%	36.05 -4%	22.99 -36%	23.63 +3%	23.57 0%	24.51 +4%	36.79 +50%	37.53 +2%	39.63 +6%	44.44 +12%	48.94 +10%	51.3 +5%	53.19 +4%	55.09 +4%	56.47 +3%	59.15 +5%	63.19 +7%	67.16 +6%

Income Statement Balance Sheet Cash Flow Statement

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Income Statement

Earnings Waterfall
Torrent Pharmaceuticals Ltd

Income Statement
Torrent Pharmaceuticals Ltd

See Also

Company

Help

Tools

Stocks

Torrent Pharmaceuticals Ltd NSE:TORNTPHARM

Income Statement

Earnings Waterfall Torrent Pharmaceuticals Ltd

Income Statement Torrent Pharmaceuticals Ltd

See Also

Company

Help

Tools

Stocks

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Earnings Waterfall
Torrent Pharmaceuticals Ltd

Income Statement
Torrent Pharmaceuticals Ltd